Dechra Pharmaceuticals (DPH)

Sector: Pharma and Biotech     Index: FTSE 250
-1.21%
-26.00p
2,125.00p
17:16 17/11/17
2,125.00p
17:16 17/11/17
DAILY VARIATION
-1.21%
-26.00p
VOLUME
133,746
REAL TIME BATS
2,128.00p
17:36 17/11/17
-1.07%
-23.00p
DATA
52 Week High
2,190.00p
52 Week Low
1,235.00p
Shares Issued
93.42m
Market Cap
£1,985.08m
RiskGrade
97
Beta
0.95
MENU

Dechra Pharmaceuticals Overview

Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. Expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. It listed in London in 2000.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 1.0% 1.0%
Div Cover 3.0 3.0
Op Mrgn 9.2% 21.2%
ROCE 23.6%
Latest F'cast
P/E 32.9 33.5
PEG 0.6 0.6
Pr/Revenue 5.5 5.5
Pr/Book 6.6
Latest F'cast
Revenue 45.1% 0.0%
PBT 96.3% n/a
EPS 50.6% 0.0%
DPS 16.1% 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2013-06-30 189.18 12.48 29.27p 23.6 0.6 37% 14.00p 2.0%
2014-06-30 193.57 21.44 36.45p 19.8 0.8 25% 15.40p 2.1%
2015-06-30 203.48 25.81 40.17p 24.5 2.4 10% 16.94p 1.7%
2016-06-30 247.56 14.55 42.95p 27.3 3.9 7% 18.46p 1.6%
2017-06-30 359.27 28.56 64.68p 26.3 0.5 51% 21.44p 1.3%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2018-06-30 396.74 89.56 73.47p 29.3 2.2 14% 23.29p 1.1%

Regulatory News

slide to see more

Newspaper Links

No results found